Comparative Long-Term Renal Allograft Outcomes of Recurrent Immunoglobulin A with Severe Activity in Kidney Transplant Recipients with and without Rituximab: An Observational Cohort Study

Recurrent IgA nephropathy (IgAN) remains an important cause of allograft loss in renal transplantation. Due to the limited efficacy of corticosteroid in the treatment of recurrent glomerulonephritis, rituximab was used in kidney transplant (KT) recipients with severe recurrent IgAN. A retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Chancharoenthana, Wiwat, Leelahavanichkul, Asada, Ariyanon, Wassawon, Vadcharavivad, Somratai, Phumratanaprapin, Weerapong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432075/
https://www.ncbi.nlm.nih.gov/pubmed/34501386
http://dx.doi.org/10.3390/jcm10173939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432075/
https://www.ncbi.nlm.nih.gov/pubmed/34501386
http://dx.doi.org/10.3390/jcm10173939

Ejemplares similares